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INTRODUCTION
Cardiac surgery associated acute kidney injury (CSA-
AKI) is a considerable complication with the incidence 
of 8.9%-39% according to current studies (1-10). It is 
the second cause of acute kidney injury (AKI) develop-
ment in the intensive care patients at er sepsis, as well 
as an independent risk factor for mortality (11-13). 
Although the incidence of postoperative AKI develop-
ment is higher in patients with preoperative chronic 
kidney disease, patients with normal preoperative re-
nal function submitted to cardiac surgery are under 
major risk as well. Remarkable characteristics of cardi-
ac surgery procedures are the use of cardiopulmonary 
bypass, aorta cross-clamping, high transfusion rates, 
and use of vasopressors and inotropes, which all con-
tribute to the risk of AKI development. Also, specii c 
risk factors associated with anesthetic, surgical and 
intensive care management, as well as unmodii able 
risk factors such as age, hypertension and peripher-
al vascular disease, contribute to the greater risk of 
postoperative AKI emergence (14). Current studies 
propose that CSA-AKI is a consequence of complex 
and dif erent pathophysiological mechanisms. h ese 
mechanisms include altered renal perfusion, alternat-
ing cycles of ischemia and reperfusion, increased oxi-
dative stress reaction, and increased renal and system-
ic inl ammatory response (15). We conducted a single 
center retrospective three-year cohort study to reveal 
the incidence of the postoperative AKI genesis, AKI 
severity, and continuous renal replacement therapy 
(RRT) use in patients with normal preoperative renal 
function submitted to cardiac surgery procedures. We 
also validated the association between preoperative 
and intraoperative risk factors and AKI development. 
We also compared the incidence of major postopera-
tive complications between the group of patients who 
developed CSA-AKI and those who did not.
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PATIENTS AND METHODS
Patient selection and study design 
We conducted a retrospective cohort study from Jan-
uary 2014 until December 2016 at the Department of 
Cardiovascular Surgery and cardiac Intensive Care 
Unit (ICU). All necessary patient data were collected 
from medical records and hospital electronic medical 
database. Our study included 1000 patients older than 
18 years submitted to urgent or scheduled cardiac sur-
gery (coronary artery bypass grat ing, valve replace-
ment, combined coronary artery bypass grat ing and 
valve replacement, Bentall procedure, supracoronary 
replacement of the ascending aorta and aortic valve 
replacement) with preoperative estimated glomerular 
i ltration rate (eGFR) >60 mL/min/1.73 m2 calculated 
on baseline serum creatinine values within the period 
of 7 days before the surgery according to the Cock-
crot -Gault equation. All patients had signed a written 
informed consent and postoperatively were submitted 
to cardiac ICU. Excluded from the study were patients 
with incomplete data, patients submitted to other type 
of cardiac surgery (transcatheter aortic valve implan-
tation, re-do operations, cardiac pacemaker and im-
plantable cardioverter dei brillator insertion, revision 
surgery, subxiphoid  pericardial  drainage, and other 
procedures that did not require use of extracorpore-
al circulation) beyond those mentioned in inclusion 
criteria, who died intraoperatively or within 48 hours 
postoperatively, and those on chronic renal hemodial-
ysis program. h e research protocol was approved by 
the institution Human Research Ethics Committee for 
cardiovascular disease.
h e primary endpoint was observation of AKI devel-
opment and AKI staging at er cardiac surgery, inci-
dence of AKI that required continuous RRT during 
the postoperative period, length of ICU and hospital 
stay, and in-hospital mortality rate. Secondary out-
comes included correlation of preoperative variables, 
intraoperative variables and major postoperative 
complications with AKI development. Postoperative 
AKI was dei ned by a modii ed dei nition of the Kid-
ney Disease: Improving Global Outcomes (KDIGO) 
AKI Workgroup, harmonizing dif erences between 
the Risk, Injury, Failure, Loss of kidney function, 
and End-stage kidney disease (RIFLE) and the Acute 
Kidney Injury Network (AKIN) dei nitions based on 
changes in serum creatinine alone (16). h e postop-
erative serum creatinine levels were obtained from 
the highest serum creatinine values measured on each 
postoperative day during patient stay in ICU and on 
surgical ward, or the highest value on the last day of 
hospital stay. We observed a rise in postoperative se-
rum creatinine by ≥26.5 μmoL within 48 hours, or a 
rise of postoperative serum creatinine by ≥1.5 baseline 
preoperative serum creatinine levels during hospital 
stay. We did not use urine output as a criterion for de-
termining AKI at er cardiac surgery because postop-
erative output is a consequence of the variables other 
than renal function, such as achieving optimal l uid 
balance, diuretic use and perioperative surgery and 
anesthesia stress reaction with hormonal and meta-
bolic imbalance. All patients were followed-up until 
discharge from the hospital. AKI group was deter-
mined as AKI stage 1, 2 or 3 according to the KDIGO 
AKI (RIFLE/AKIN) guidelines. It means that AKI was 
dei ned by the RIFLE criteria using maximal change 
in serum creatinine until release from the hospital 
compared with baseline serum creatinine values be-
fore surgery. Patients were stratii ed according to the 
highest RIFLE class (Risk, Injury, or Failure) attained 
by serum creatinine. At the same time, AKIN crite-
ria were also used in determining AKI using the strict 
dei nition for increments of serum creatinine within 
a 48-hour interval (16). It means that we compared 
daily serum creatinine value with subsequent levels 
for the next 2 days until discharge from the hospital. 
h e most severe degree of AKI was recorded as i nal 
AKIN stage. Control no-AKI group included patients 
with normal postoperative renal function according to 
the KDIGO AKI (RIFLE/AKIN) criteria during clini-
cal observation. h e indications for continuous RRT 
in the AKI group included uremia, volume overload, 
biochemical abnormalities, or AKI with diuretic resis-
tance, and were based on clinical judgment (17). Oth-
er indications for continuous RRT in the cohort group 
were severe hemodynamic instability, severe systemic 
inl ammatory response, cardiac decompensation, and 
presence of any other organ failure accompanied by 
AKI (17).
Patient preoperative characteristics and postopera-
tive outcomes 
We collected data on the following preoperative vari-
ables as the possible predictors of AKI development: 
age, gender, weight, height, let  ventricular ejection 
fraction, preoperative insertion and perioperative use 
of intra-aortic balloon pump (IABP), hemoglobin 
and hematocrit levels measured within 7 days prior to 
surgery, urgency of surgery (dei ned as scheduled or 
urgent (within 24 hours at er initial diagnosis)), and 
Euroscore II (18). Patient preoperative comorbidities 
were bundled into prior myocardial infarction, neuro-
logic disease (history of prior transient ischemic attack 
or stroke), preexisting chronic obstructive pulmonary 
disease (COPD), arterial hypertension, and diabetes 
treated with oral agents or insulin. Surgery duration 
(from skin incision to closure) was recorded in the in-
traoperative period. Pump time and cross clamp time 
were recorded in the perfusion record. Major com-
plications were dei ned as the number of transfused 
packed red blood cell (PRBC) units, duration of the 
postoperative mechanical ventilation, length of ICU 
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stay, length of hospital stay, in-hospital infection rate, 
and in-hospital mortality rate.
Statistical analysis 
Descriptive statistics for categorical variables were re-
ported as frequency and percentage while continuous 
variables were reported as mean ± standard devia-
tion. Categorical variables were analyzed using Pear-
son χ2-test. Continuous variables were analyzed using 
unpaired T-test. Univariate analysis was applied to 
evaluate the potential preoperative and intraoperative 
risk factors and major postoperative complications 
associated with CSA-AKI. h e values of p<0.05 were 
considered statistically signii cant. h e SPSS statistical 
sot ware version 24 was used in all analyses.
RESULTS
In our study, cardiac surgery was performed on 1441 
patients between January 2014 and December 2016. 
Eighty patients were excluded from the study due to 
incomplete data, 3 patients were on chronic hemo-
dialysis program, 19 patients were disqualii ed due 
to submission to cardiac surgery type other than re-
quested in inclusion criteria, and 339 patients had pre-
operative eGFR <60 mL/min/1.73 m2. h e i nal study 
cohort consisted of 1000 patients; 151 patients devel-
oped postoperative AKI. h e overall AKI incidence 
was 15.1%. h e incidence of AKI was 12.8% (n=128) 
in stage 1; 1.9% (n=19) in stage 2; and 0.4% (n=4) in 
stage 3 according to the KDIGO AKI (RIFLE/AKIN) 
criteria. In the entire cohort, 11 (1.1%) patients re-
quired postoperative continuous RRT. Continuous 
veno-venous hemodiai ltration (CVVHDF) was the 
modality applied (19). h e incidence of continuous 
RRT in the AKI group was 2.65% or 0.4% of the total 
cohort (n=4). h e indications for initiating CVVHDF 
were volume overload, biochemical abnormalities, 
uremia or AKI with diuretic resistance (17). Moreover, 
indications for applying continuous RRT in 7 patients 
without AKI in the cohort (0.7% of the total cohort) 
were signii cant hemodynamic instability, cardiogen-
ic shock, and severe systemic inl ammatory response 
(17). Control no-AKI group consisted of 849 (84.9%) 
patients who did not develop AKI during clinical 
observation. We did not observe any signii cant dif-
ferences between AKI and no-AKI groups in the 
following preoperative variables: gender, height, let  
ventricular ejection fraction, preoperative hemoglo-
bin and hematocrit levels (Table 1). However, the AKI 
group was signii cantly older and had greater body 
mass than no-AKI group (Table 1). Also, periopera-
tive use of IABP was signii cantly associated with AKI 
development (Table 1). AKI group had a signii cant-
ly higher Euroscore II and was more ot en submitted 
to urgent cardiac surgery in comparison to no-AKI 
group (Table 1). We found no dif erences between AKI 
and no-AKI group in preoperative comorbidities such 
as history of prior myocardial infarction and neuro-
logic disease (Table 1). Besides, although the history 
of COPD had a higher incidence in the AKI group 
in comparison to no-AKI, we did not i nd signii cant 
correlation between postoperative AKI genesis and 
preexisting COPD (Table 1). Interestingly, arterial hy-
pertension was present in more than 80% of patients 
in both groups but there was no signii cant correlation 
between CSA-AKI and preoperative arterial hyperten-
sion (Table 1). However, we showed that the history of 
diabetes treated with oral agents was associated with 
postoperative AKI development (Table 1). Also, lon-
ger duration of surgery, pump time and aortic cross-
clamp time were signii cantly longer in the AKI group 
in comparison to no-AKI group and associated with 
postoperative AKI development (Ta ble 2). h us, AKI 
patients had signii cantly higher transfusion of PRBC 
units during clinical observation in comparison to no-
AKI group (Table 3). Other major complications as-
sociated with AKI development were longer length of 
ICU stay, longer duration of postoperative mechanical 
ventilation, and greater in-hospital mortality rate (Ta-
ble 3). According to the studies, prolonged intubation 
was dei ned as mechanical ventilation for >24 hours 
postoperatively (5). Our study revealed that AKI 
group did not only have longer duration of postoper-
ative mechanical ventilation than no-AKI group, but 
also had a signii cantly prolonged intubation (mean ± 
SD: 32.39±53.9 hours) (Table 3). Interestingly, we did 
not i nd signii cant dif erence in the length of hospital 
stay between AKI and no-AKI groups (Table 3). h e 
CSA-AKI in-hospital mortality rate was 2.65% (n=4). 
Moreover, the overall mortality rate in patients who 
had continuous RRT during the study was 27.27% 
(n=3), while all AKI patients who required contin-
uous RRT survived. At discharge from the hospital, 
according to RIFLE classii cation, 2 AKI patients who 
had continuous RRT recovered their renal function to 
Risk class, 1 patient recovered renal function to Injury 
class, and 1 patient had loss of kidney function. We did 
not i nd signii cant dif erence in in-hospital infection 
rate between AKI and no-AKI groups (Table 3).
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Table 1 
Selected patient preoperative characteristics and 
comorbidities expressed as mean ± SD and percentage at er 










Age (yrs) 65.95±9.40 64.19±9.66 0.04
Gender
 Female 31 (21%) 174 (20%) 0.95
 Male 120 (79%) 675 (80%)
Height (cm) 172.38±9.26 172.15±8.89 0.77
Weight (kg) 93.06±15.08 87.67±13.87 <0.001
Left ventricle ejection frac-
tion (%)
59±9 58±11 0.47
Hemoglobin (g/L) 139.05±16.11 140.01±17.62 0.54
Hematocrit (%) 41.67±5.10 41.71±6.12 0.93
Preoperative IABP 14 (9.27%) 38 (4.48%) 0.015
Euroscore II (%) 5.22±8.89 3.25±6.46 <0.001
Comorbidity
Prior myocardial infarction 31 (20.53%) 132 (15.55%) 0.13
Arterial hypertension 123 (81.46%) 720 (84.81%) 0.29
Diabetes controlled with oral 
agents/insulin
53 (35%) 121 (14%) <0.001
Chronic obstructive pulmo-
nary disease
20 (13.25%) 131 (86.75%) 0.25
Neurologic disease 10 (6.62%) 50 (5.89%) 0.73
Surgery urgency
 Urgent 56 (37.09%) 232 (27.33%) 0.003
 Scheduled 95 (62.91%) 617 (72.67%)
AKI – acute kidney injury; IABP – intra-aortic balloon pump
Table 2 
Association between intraoperative variables and cardiac 
surgery associated acute kidney injury 
Intraoperative variable AKI No AKI p
Surgery duration (min) 273.58±75.58 258.55±60.35 0.007
Pump time (min) 94.70±52.24 83.14±33.26 0.001
Cross clamp time (min) 58.83±25.53 49.03±16.30 <0.001
AKI – acute kidney injury; values are expressed as mean ± SD; p 
value <0.05 was considered signii cant
Table 3 
Patient outcomes at er cardiac surgery expressed as mean ± 
SD and percentage 
AKI No AKI p
Total transfusion of PRBC (units) 4.35±5.73 2.78±3.43 <0.001
Patients transfused with PRBC 
n (%)
108 (71.52%) 545 (64.19%) 0.08
Duration of mechanical ventila-
tion (hours)
32.39±53.92 14.2±29.52 <0.001
ICU length of stay (hours) 133.47±146.03 73.54±76.99 <0.001
Overall length of hospital stay 
(days)
15.14±9.93 13.79±7.62 0.068
In-hospital infection rate, n (%) 1 (0.66%) 2 (0.24%) 0.377
In-hospital mortality rate, n (%) 4 (2.65%) 7 (0.82%) 0.048
AKI – acute kidney injury; PRBC – packed red blood cells: ICU – in-
tensive care unit; p value <0.05 was considered signii cant
DISCUSSION
Cardiac surgery associated acute kidney injury is not 
only an independent risk factor for mortality, but also a 
serious complication with long-term consequences in 
every aspect of human life in the patients who develop 
it regardless of its severity. h ere are many preoperative 
renal risk stratii cation models and new renal biomark-
ers in the process of clinical and experimental research 
validation of the prognostic ability to timely identify 
AKI development. h e most popular is the Cleveland 
Clinic Score (CCS) (also called the h akar score) (20). 
It is the best validated and most predictive tool, but 
only for serious CSA-AKI that requires RRT (21-24). 
h e CCS is a predictive risk model based on preopera-
tive risk factors for CSA-AKI (20,22-26). h e weakness 
of this model is that it does not include intraoperative 
parameters that could increase its prognostic power 
and AKI severity stratii cation. As opposed to CCS in 
our study we included patients with normal preopera-
tive renal function dei ned as eGFR >60 mL/min/1.73 
m2 calculated by Cockcrot -Gault equation and retro-
spectively validated correlation of almost all preopera-
tive risk factors of the CCS, except for previous cardiac 
surgery, with CSA-AKI development. We also wanted 
to investigate a three-year review of the AKI incidence, 
AKI severity and use of continuous RRT (CVVHDF) 
in our hospital, and compare it with current literature. 
h ereby, the incidence of CSA-AKI in our centre was 
15.1%, which is in the CSA-AKI reported range of 8.9% 
to 39%, depending on AKI dei nition (1-10). Our study 
acknowledged that AKI requiring continuous RRT oc-
curred in 2.65% of AKI patients and 0.40% of the total 
cohort. According to the literature, AKI that requires 
RRT occurs in 2%-5% of patients following cardiac 
surgery and is associated with a mortality rate of up to 
S. Sakan, Z. Povšić-Čevra, K. Tomulić Brusich, V. Juranko, D. Prajdić-Predrijevac, M. Novkovski, Z. Baudoin
A single center retrospective study of cardiac surgery associated acute kidney injury - incidence and outcomes
Acta Med Croatica, 71 (2017) 285-291
289
63% (20,27-30). It is important to emphasize that all 
AKI patients who required RRT in our study survived. 
h ere are several explanations. First is careful preop-
erative renal risk prediction and stratii cation, as well 
as implementation of measures that best optimize pre-
operative renal function such as withholding nonste-
roidal anti-inl ammatory drugs, angiotensin-convert-
ing enzyme (ACE) inhibitors, angiotensin II receptor 
blockers (ARBs), and metformin for at least 24 hours 
before surgery (31,32). Although studies about preop-
erative use of ACE inhibitors or ARBs and incidence of 
CSA-AKI are controversial and recommend risk/ben-
ei t clinical analysis, the practice in our hospital is that 
they are stopped a day before surgery (17,33,34). In-
traoperative factors such as less invasive surgical tech-
niques, shorter duration and optimal cardiopulmonary 
bypass techniques, shorter aortic cross-clamp time and 
avoiding aortic clamping during coronary artery by-
pass grat ing are also important factors that contribute 
to renal protection. Signii cantly, current studies have 
shown that early and judicious RRT initiation in pa-
tients with postoperative AKI evolution, which is di-
uretic resistance and has preserved hourly urine out-
put produces better survival rate (17,35,36). Moreover, 
the use of CVVHDF modality in postcardiac patients 
of ers better survival due to better inl ammatory me-
diator removal, less hemodynamic instability, as well 
as superiority in mortality rate and recovery of renal 
function (19,37). So, we coni rmed that our results 
were consistent with the current literature. Moreover, 
consistently with h akar et al., our study verii ed that 
preoperative variables such as perioperative use of 
IABP, diabetes and urgent surgery were signii cant pre-
dictors of AKI emergence (9). As opposed to h akar et 
al., we did not prove female gender, history of COPD 
and arterial hypertension as signii cant AKI risk fac-
tors. Interestingly, we revealed that age and weight as 
anthropometric measures were signii cant risk factors 
for CSA-AKI development. Patients with CSA-AKI 
were older and had greater weight. In accordance with 
Wong et al., our results also recognized longer surgery 
duration, longer pump time and longer cross-clamp 
time as intraoperative risk factors for AKI development 
(24). However, we must emphasize that although AKI 
patients in our study had pump time 3-fold and cross-
clamp time 1.5-fold shorter than AKI patients in the 
study by Wong et al., they still had a signii cant risk of 
AKI development (24). We did not detect dif erences in 
the frequency of transfusion between AKI and no-AKI 
groups. However, when transfused, patients in the AKI 
group received a considerably larger number of PRBC 
units in comparison to no-AKI group. Since transfu-
sion of PRBC is potentially a modii able AKI risk fac-
tor, we should always try in clinical practice to delay it 
as long as possible and apply perioperative measures 
and procedures for reducing the transfusion rate and 
triggers. Acknowledgment to the recognition of AKI 
as a serious postoperative complication was emergence 
of signii cant major complications in AKI patients, 
such as prolonged postoperative mechanical ventila-
tion, longer ICU length of stay and higher in-hospital 
mortality rate. h ese results were in accordance with 
current studies (5). However, we did not i nd dif erence 
in the length of hospital stay between AKI and no-AKI 
groups. Other studies indicate opposite (5). In addi-
tion, we did not coni rm signii cant dif erence in the 
infection rate as a major complication between AKI 
and no-AKI groups. Our results showed some poten-
tial clinical and research implications. Firstly, although 
age-associated loss of kidney function has been recog-
nized for a while, our study once again coni rmed it as 
a signii cant risk factor for CSA-AKI genesis. Another 
novelty of our research was validation of weight as a 
strong preoperative risk factor in the CSA-AKI gene-
sis. Since we are aware of obesity and overweight as a 
growing population problem worldwide, especially in 
younger population, this simple anthropometric mea-
sure deserves further clinical research in the i eld of 
CSA-AKI. h erefore, we believe that further researches 
are necessary to validate age and weight as preopera-
tive risk factors for CSA-AKI development and maybe 
incorporate these variables in the current preoperative 
risk factor tools. Interestingly, we did not i nd dif er-
ence in the length of hospital stay between AKI and 
no-AKI groups. One explanation is that in cardiac sur-
gery, there are many more major complications such 
as revision surgery, hemorrhage, postoperative deliri-
um and neurologic sequels that we did not investigate 
but which inl uence the patient postoperative course. 
So, our study should be broadened in these aspects. 
We also validated pump time, cross-clamp time and 
transfusion rate as strong modii able intraoperative 
CSA-AKI risk factors. Every center should be directed 
in improving these factors. It means that by improving 
and developing surgical technique, the pump time and 
cross-clamp time should be shorter. Also, transfusion 
rates should be lower. Other study results were mostly 
consistent with the current literature.
CONCLUSION
Once again, our study revealed the importance of 
timely recognizing AKI. Also, we reai  rmed CSA-
AKI as a serious complication with a high incidence of 
15.1% in healthy patients submitted to cardiac surgery. 
We also verii ed the utility of preoperative risk predic-
tion models in AKI prediction. We also demonstrated 
that some intraoperative CSA-AKI risk factors were 
modii able, and we should make ef orts to improve 
them and decrease their inl uence on CSA-AKI emer-
gence as much as possible. 
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Uvod: Akutno bubrežno oštećenje (ABO) je ozbiljna komplikacija kardijalne kirurgije. Istraživanja su pokazala da je 
kardijalna kirurgija po učestalosti drugi uzrok ABO u jedinicama intenzivnog liječenja. Metode: Provedeno je retrospektivno 
istraživanje za razdoblje od tri godine kako bi se utvrdila incidencija ABO, odredio stupanj ozbiljnosti ABO te incidencija 
kontinuirane bubrežne nadomjesne terapije u bolesnika s urednom prijeoperacijskom bubrežnom funkcijom podvrgnutih 
kardijalnom zahvatu. U istraživanje je bilo uključeno 1000 ispitanika. Ovim istraživanjem htjeli smo potvrditi povezanost 
između prijeoperacijskih čimbenika rizika iz prediktivnog modela Cleveland Clinic Score i intraoperacijskih rizičnih varijabla 
kardijalne kirugije i anestezije s nastankom poslijeoperacijskog ABO. Sekundarni ishod je pokazao incidenciju velikih 
poslijeoperacijskh komplikacija u bolesnika s ABO povezanim s kardijalnim zahvatom. Rezultati: Ukupna incidencija 
ABO bila je 15,1 % (n=151). Učestalost ispitanika sa stadijem 1 ABO bila je 12,8 % (n=128), sa stadijem 2 1,9 % (n=19) 
te sa stadijem 3 0,4 % (n=4) klasifi ciranima prema kriteriju KDIGO AKI (RIFLE/AKIN). Učestalost primjene kontinuirane 
bubrežne nadomjesne terapije u ispitanika s ABO iznosila je 2,65 %, odnosno 0,4 % cijele kohorte ispitanika (n=4). Bolnička 
stopa smrtnosti bolesnika s ABO bila je 2,65 % (n=4). Zanimljivo je da su svi bolesnici podvrgnuti kontinuiranoj bubrežnoj 
nadomjesnoj terapiji zbog ABO preživjeli. Zaključak: Ovim smo istraživanjem još jednom potvrdili važnost pravodobnog 
prepoznavanja poslijeoperacijskog ABO kao ozbiljne komplikacije kardijalnih zahvata. Potvrdili smo da uporaba 
prijeoperacijskh prediktivnih modela rizika za nastanak ABO nakon kardijalnih zahvata olakšava prepoznavanje rizičnih 
bolesnika i pravodobnu primjenu mjera prevencije i liječenja ABO. Najpoznatiji prediktivni model je Cleveland Clinic Score.
Ključne riječi: akutno bubrežno oštećenje; kardijalna kirurgija; dijaliza
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